Takeshi Soma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Takeshi Soma has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Kohji Nishida
Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita Osaka, Japan
6 shared publications- Kohji Nishida
Department of Ophthalmology, Graduate School of Medicine, The University of Osaka, Suita, Japan
4 shared publications Naoyuki Maeda
Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita Osaka, Japan
4 shared publicationsShizuka Koh
Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita Osaka, Japan
4 shared publicationsYoshinori Oie
Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita Osaka, Japan
4 shared publicationsMotokazu Tsujikawa
Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan,
3 shared publications
Latest Publications
- Open Access
- 3 February 2025
- Published by Wolters Kluwer Health in Cornea
- Vol. 45 (2) , 155-159
National Survey on Corneal Transplantation in Japan
Purpose: To report the results of a national survey on corneal transplantation in Japan. Methods: The Japan Cornea Society and the Keratoplasty Society of Japan conducted a national survey on corneal transplantation performed from 2017 to 2019. Data from various institutions were collected through an online database and subsequently analyzed. Results: In total, 4951 cases from 44 facilities were documented. The leading cause of corneal transplantation was corneal edema (CE), which accounted for 39.3% of cases, followed by repeat keratoplasty at 27.7%. Among CE cases, postcataract surgery was the most prevalent (25.1%), followed by postglaucoma surgery (20.8%) and laser iridotomy–induced CE (18.2%). Fuchs endothelial corneal dystrophy was the fourth most common cause (10.9%). Regarding surgical methods, Descemet stripping automated endothelial keratoplasty was the most common, used in 41.3% of procedures, followed by penetrating keratoplasty at 37.1%. Deep anterior lamellar keratoplasty and Descemet membrane endothelial keratoplasty were used in 8.1% and 2.6% of cases, respectively. One year after transplantation, graft clarity was maintained in 80.5% of cases, and regrafting was necessary in 15.2% of instances. Conclusions: The national survey reveals that CE is the most frequent indication for corneal transplantation in Japan. Increases in cases from glaucoma surgery and Fuchs endothelial corneal dystrophy were noted among patients with CE. Endothelial keratoplasty, especially Descemet stripping automated endothelial keratoplasty, is now the preferred surgical technique for these transplants.
- 3 February 2025
- Published by Wolters Kluwer Health in Cornea
- Vol. 45 (2) , 155-159
Open AccessNational Survey on Corneal Transplantation in Japan
Purpose: To report the results of a national survey on corneal transplantation in Japan. Methods: The Japan Cornea Society and the Keratoplasty Society of Japan conducted a national survey on corneal transplantation performed from 2017 to 2019. Data from various institutions were collected through an online database and subsequently analyzed. Results: In total, 4951 cases from 44 facilities were documented. The leading cause of corneal transplantation was corneal edema (CE), which accounted for 39.3% of cases, followed by repeat keratoplasty at 27.7%. Among CE cases, postcataract surgery was the most prevalent (25.1%), followed by postglaucoma surgery (20.8%) and laser iridotomy–induced CE (18.2%). Fuchs endothelial corneal dystrophy was the fourth most common cause (10.9%). Regarding surgical methods, Descemet stripping automated endothelial keratoplasty was the most common, used in 41.3% of procedures, followed by penetrating keratoplasty at 37.1%. Deep anterior lamellar keratoplasty and Descemet membrane endothelial keratoplasty were used in 8.1% and 2.6% of cases, respectively. One year after transplantation, graft clarity was maintained in 80.5% of cases, and regrafting was necessary in 15.2% of instances. Conclusions: The national survey reveals that CE is the most frequent indication for corneal transplantation in Japan. Increases in cases from glaucoma surgery and Fuchs endothelial corneal dystrophy were noted among patients with CE. Endothelial keratoplasty, especially Descemet stripping automated endothelial keratoplasty, is now the preferred surgical technique for these transplants.
- 24 April 2024
- Published by Wolters Kluwer Health in Eye & Contact Lens: Science & Clinical Practice
- Vol. 50 (6) , 276-278
Continuous Corneal Endothelial Damage by Chlorhexidine Alcohol Used for Disinfection in Nonophthalmic Surgery
Purpose: To report a case of corneal endothelial damage caused by alcohol-containing chlorhexidine gluconate (CG-A) and its progression over time. Methods: This was a case report. Results: A 22-year-old man underwent neurosurgery under general anesthesia. CG-A (1%) was used for disinfection after the application of corneal protection tape. Postoperatively, the patient presented with hyperemia and swelling of the left conjunctiva and was referred to our department. Initial examination revealed left corneal epithelial erosion and corneal edema, which improved on postoperative day 14. The corneal endothelial cell density (ECD) was 3,345 cells/mm2 on day 14, decreased rapidly to 2,090 cells/mm2 on day 42, and slowly reduced to 1,122 cells/mm2 on day 168. Thereafter, no decrease in ECD was observed. Conclusions: CG formulations can lead to a persistent decrease in ECD over several months, even after improvement of acute corneal edema.
- 24 April 2024
- Published by Wolters Kluwer Health in Eye & Contact Lens: Science & Clinical Practice
- Vol. 50 (6) , 276-278
Continuous Corneal Endothelial Damage by Chlorhexidine Alcohol Used for Disinfection in Nonophthalmic Surgery
Purpose: To report a case of corneal endothelial damage caused by alcohol-containing chlorhexidine gluconate (CG-A) and its progression over time. Methods: This was a case report. Results: A 22-year-old man underwent neurosurgery under general anesthesia. CG-A (1%) was used for disinfection after the application of corneal protection tape. Postoperatively, the patient presented with hyperemia and swelling of the left conjunctiva and was referred to our department. Initial examination revealed left corneal epithelial erosion and corneal edema, which improved on postoperative day 14. The corneal endothelial cell density (ECD) was 3,345 cells/mm2 on day 14, decreased rapidly to 2,090 cells/mm2 on day 42, and slowly reduced to 1,122 cells/mm2 on day 168. Thereafter, no decrease in ECD was observed. Conclusions: CG formulations can lead to a persistent decrease in ECD over several months, even after improvement of acute corneal edema.
- 30 September 2022
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 261 (3) , 761-767
Assessment of the corneal biomechanical features of granular corneal dystrophy type 2 using dynamic ultra-high-speed Scheimpflug imaging
Purpose To evaluate the corneal biomechanical features of eyes with granular corneal dystrophy type 2 (GCD2) by analyzing corneal biomechanical indices obtained using a Corvis ST (CST) dynamic ultra-high-speed Scheimpflug imaging device. Methods In this retrospective case–control study, 35 CST parameters were compared in normal eyes (control) and eyes of patients with GCD2 treated at Osaka University Hospital, Osaka, Japan. The parameters included the Corvis Biomechanical Index (CBI), which is important in differentiating eyes with keratoconus from normal eyes. We measured the deposition rates of lesions in the central 7-mm region of the eye and assessed the correlation between the deposition rate and the CBI. Results Twenty-one eyes with GCD2 and 23 control eyes were analyzed. Eyes with GCD2 showed significantly less corneal stiffness in 15 CST parameters than did control eyes. In particular, the CBI was remarkably higher in eyes with GCD2 than in control eyes (P = 0.000006). Additionally, the deposition rate and the CBI were positively correlated. Conclusions GCD2 eyes had softer corneas than did control eyes in most biomechanical CST parameters, and one of the parameters (the CBI) was linked to the rate of deposited lesions. Since IOP may be underestimated in GCD2 eyes, management should be especially careful in GCD2 cases complicated by glaucoma.
- 30 September 2022
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 261 (3) , 761-767
Assessment of the corneal biomechanical features of granular corneal dystrophy type 2 using dynamic ultra-high-speed Scheimpflug imaging
Purpose To evaluate the corneal biomechanical features of eyes with granular corneal dystrophy type 2 (GCD2) by analyzing corneal biomechanical indices obtained using a Corvis ST (CST) dynamic ultra-high-speed Scheimpflug imaging device. Methods In this retrospective case–control study, 35 CST parameters were compared in normal eyes (control) and eyes of patients with GCD2 treated at Osaka University Hospital, Osaka, Japan. The parameters included the Corvis Biomechanical Index (CBI), which is important in differentiating eyes with keratoconus from normal eyes. We measured the deposition rates of lesions in the central 7-mm region of the eye and assessed the correlation between the deposition rate and the CBI. Results Twenty-one eyes with GCD2 and 23 control eyes were analyzed. Eyes with GCD2 showed significantly less corneal stiffness in 15 CST parameters than did control eyes. In particular, the CBI was remarkably higher in eyes with GCD2 than in control eyes (P = 0.000006). Additionally, the deposition rate and the CBI were positively correlated. Conclusions GCD2 eyes had softer corneas than did control eyes in most biomechanical CST parameters, and one of the parameters (the CBI) was linked to the rate of deposited lesions. Since IOP may be underestimated in GCD2 eyes, management should be especially careful in GCD2 cases complicated by glaucoma.
- Open Access
- 18 June 2022
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 27, 101623
Treatment of Descemet's membrane detachment after primary Descemet's stripping automated endothelial keratoplasty during surgery using intraoperative optical coherence tomography
- 18 June 2022
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 27, 101623
Open AccessTreatment of Descemet's membrane detachment after primary Descemet's stripping automated endothelial keratoplasty during surgery using intraoperative optical coherence tomography
- 25 May 2022
- Published by Wolters Kluwer Health in Cornea
- Vol. 41 (11) , 1447-1450
A Case of Clinically Atypical Gelatinous Drop-like Corneal Dystrophy With Unilateral Recurrent Amyloid Depositions
Purpose: The purpose of this article was to describe the successful diagnosis and management of clinically atypical, unilateral, gelatinous drop-like corneal dystrophy (GDLD) in a pediatric patient. Methods: This study was a case report. Results: A 7-year-old Japanese girl was referred to our clinic with right corneal opacity for over 3 years. Slitlamp examination revealed a white, protruding, paracentral corneal opacity with an irregular surface and tiny stromal lattice figures with subepithelial opacities. No trichiasis or epiblepharon was observed, and the patient's right corrected distance visual acuity (CDVA) was 18/20. The contralateral cornea was intact but demonstrated fluorescein uptake. After 8 months, the right CDVA worsened from 18/20 to 6/20, and corneal epithelial scraping was performed. Histopathological analysis revealed amyloid nodules in the subepithelial layer and in the anterior corneal stroma stained with Congo red, which reoccurred 2 months after the procedure, and corneal dystrophy was suspected. Isolation and sequencing of the genomic DNA revealed a homozygous p.Gln118Ter. mutation in TACSTD2 in the patient and heterozygous p.Gln118Ter. mutations in both parents. GDLD was diagnosed; bilateral use of therapeutic soft contact lenses was prescribed after the first corneal scraping. No additional surgical intervention was required for the right eye for 4.5 years. CDVA of the contralateral left eye has been successfully maintained at 30/20 over this period, without emergence of nodular lesions or corneal opacities. Conclusions: We encountered a patient with early, atypical GDLD, who was definitively diagnosed using genomic DNA sequencing. GDLD should be a part of the differential diagnosis in patients presenting with unilateral, recurrent amyloid deposition.
- 25 May 2022
- Published by Wolters Kluwer Health in Cornea
- Vol. 41 (11) , 1447-1450
A Case of Clinically Atypical Gelatinous Drop-like Corneal Dystrophy With Unilateral Recurrent Amyloid Depositions
Purpose: The purpose of this article was to describe the successful diagnosis and management of clinically atypical, unilateral, gelatinous drop-like corneal dystrophy (GDLD) in a pediatric patient. Methods: This study was a case report. Results: A 7-year-old Japanese girl was referred to our clinic with right corneal opacity for over 3 years. Slitlamp examination revealed a white, protruding, paracentral corneal opacity with an irregular surface and tiny stromal lattice figures with subepithelial opacities. No trichiasis or epiblepharon was observed, and the patient's right corrected distance visual acuity (CDVA) was 18/20. The contralateral cornea was intact but demonstrated fluorescein uptake. After 8 months, the right CDVA worsened from 18/20 to 6/20, and corneal epithelial scraping was performed. Histopathological analysis revealed amyloid nodules in the subepithelial layer and in the anterior corneal stroma stained with Congo red, which reoccurred 2 months after the procedure, and corneal dystrophy was suspected. Isolation and sequencing of the genomic DNA revealed a homozygous p.Gln118Ter. mutation in TACSTD2 in the patient and heterozygous p.Gln118Ter. mutations in both parents. GDLD was diagnosed; bilateral use of therapeutic soft contact lenses was prescribed after the first corneal scraping. No additional surgical intervention was required for the right eye for 4.5 years. CDVA of the contralateral left eye has been successfully maintained at 30/20 over this period, without emergence of nodular lesions or corneal opacities. Conclusions: We encountered a patient with early, atypical GDLD, who was definitively diagnosed using genomic DNA sequencing. GDLD should be a part of the differential diagnosis in patients presenting with unilateral, recurrent amyloid deposition.
- 1 August 2021
- Published by Elsevier in Contact Lens and Anterior Eye
- Vol. 44 (4) , 101405
Optimizing correction of coma aberration in keratoconus with a novel soft contact lens
- 1 August 2021
- Published by Elsevier in Contact Lens and Anterior Eye
- Vol. 44 (4) , 101405
Optimizing correction of coma aberration in keratoconus with a novel soft contact lens
- Open Access
- 19 May 2021
- Published by Springer Nature in BMC Ophthalmology
- Vol. 21 (1) , 1-7
Fusarium infection complicating rheumatic keratitis that acutely progressed to endophthalmitis during regular infusion of tocilizumab: a case report
Background: Filamentous fungi are ubiquitous in plants, water, and soil. The predominant fungi that infect the human cornea include Fusarium and Aspergillus species. The onset of fungal endophthalmitis is indolent, and typically takes weeks to months to develop after corneal infection. We report a case of Fusarium infection complicating rheumatic keratitis that acutely progressed to endophthalmitis during intravenous tocilizumab therapy. Case presentation: A 65-year-old female patient was referred to our department due to pain and decreased vision in her left eye. Slit-lamp examination showed a white focus on the upper peripheral cornea, hypopyon, anterior chamber fibrin formation, marked ciliary hyperemia, and whole corneal epithelial defects. As the corneal scraping smear was positive for filamentous fungi and Fusarium species were detected by aqueous humor polymerase chain reaction, anti-fungal therapy was started. Although the initial response to anti-fungal therapy was good, we observed corneal infiltration, worsening hypopyon, and vitreous opacity after tocilizumab infusion. Given that the infection continued to progress despite conservative therapy, we performed penetrating keratoplasty combined with vitrectomy. After removal of the white focus beneath the intraocular lens, a temporary corneal prosthesis was mounted and the dense vitreous opacity was removed. Finally, a frozen donor graft was sutured in place. The corneal infiltration, hypopyon, and vitreous opacity all disappeared after the operation. Conclusion: The rapid progression of Fusarium keratitis to endophthalmitis in a patient who was receiving a regular infusion of tocilizumab demonstrates that ocular condition should be closely monitored during systemic tocilizumab administration due to increased risk of infection.
- 19 May 2021
- Published by Springer Nature in BMC Ophthalmology
- Vol. 21 (1) , 1-7
Open AccessFusarium infection complicating rheumatic keratitis that acutely progressed to endophthalmitis during regular infusion of tocilizumab: a case report
Background: Filamentous fungi are ubiquitous in plants, water, and soil. The predominant fungi that infect the human cornea include Fusarium and Aspergillus species. The onset of fungal endophthalmitis is indolent, and typically takes weeks to months to develop after corneal infection. We report a case of Fusarium infection complicating rheumatic keratitis that acutely progressed to endophthalmitis during intravenous tocilizumab therapy. Case presentation: A 65-year-old female patient was referred to our department due to pain and decreased vision in her left eye. Slit-lamp examination showed a white focus on the upper peripheral cornea, hypopyon, anterior chamber fibrin formation, marked ciliary hyperemia, and whole corneal epithelial defects. As the corneal scraping smear was positive for filamentous fungi and Fusarium species were detected by aqueous humor polymerase chain reaction, anti-fungal therapy was started. Although the initial response to anti-fungal therapy was good, we observed corneal infiltration, worsening hypopyon, and vitreous opacity after tocilizumab infusion. Given that the infection continued to progress despite conservative therapy, we performed penetrating keratoplasty combined with vitrectomy. After removal of the white focus beneath the intraocular lens, a temporary corneal prosthesis was mounted and the dense vitreous opacity was removed. Finally, a frozen donor graft was sutured in place. The corneal infiltration, hypopyon, and vitreous opacity all disappeared after the operation. Conclusion: The rapid progression of Fusarium keratitis to endophthalmitis in a patient who was receiving a regular infusion of tocilizumab demonstrates that ocular condition should be closely monitored during systemic tocilizumab administration due to increased risk of infection.
- Open Access
- 17 January 2021
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 193 (3) , E110-E111
Perforation cornéenne due à une kératoconjonctivite gonococcique
- 17 January 2021
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 193 (3) , E110-E111
Open AccessPerforation cornéenne due à une kératoconjonctivite gonococcique
- Open Access
- 1 November 2020
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 192 (44) , E1361
Corneal perforation secondary to gonococcal keratoconjunctivitis
- 1 November 2020
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 192 (44) , E1361
Open AccessCorneal perforation secondary to gonococcal keratoconjunctivitis
- 7 August 2019
- Published by Wolters Kluwer Health in Cornea
- Vol. 38 (1) , S42-S44
NS Endo-Inserter: A New Graft Inserter for Descemet Stripping Automated Endothelial Keratoplasty
Although Descemet stripping automated endothelial keratoplasty (DSAEK) has become widespread as a first choice for the treatment of bullous keratopathy, corneal endothelial cell loss during the early postoperative period caused by intraoperative mechanical stress to the donor endothelium remains a clinical challenge. At present, a pull-through technique is the standard procedure for graft delivery in DSAEK. However, the anterior chamber is likely to collapse during graft delivery in patients with a small eye or shallow anterior chamber, as often seen in Asian patients, leading to endothelial cell damage. To solve this problem, we developed a new device for DSAEK, known as NS Endo-Inserter, in which the graft flows into the anterior chamber in a balanced salt solution in one step. This article reviews the features of NS Endo-Inserter and the outcomes of DSAEK using this device.
- 7 August 2019
- Published by Wolters Kluwer Health in Cornea
- Vol. 38 (1) , S42-S44
NS Endo-Inserter: A New Graft Inserter for Descemet Stripping Automated Endothelial Keratoplasty
Although Descemet stripping automated endothelial keratoplasty (DSAEK) has become widespread as a first choice for the treatment of bullous keratopathy, corneal endothelial cell loss during the early postoperative period caused by intraoperative mechanical stress to the donor endothelium remains a clinical challenge. At present, a pull-through technique is the standard procedure for graft delivery in DSAEK. However, the anterior chamber is likely to collapse during graft delivery in patients with a small eye or shallow anterior chamber, as often seen in Asian patients, leading to endothelial cell damage. To solve this problem, we developed a new device for DSAEK, known as NS Endo-Inserter, in which the graft flows into the anterior chamber in a balanced salt solution in one step. This article reviews the features of NS Endo-Inserter and the outcomes of DSAEK using this device.